Kala Pharmaceuticals Inc (KALA)

Kala Pharmaceuticals (KALA) Stock Price & Analysis


KALA Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$3.54 - $56.72
Previous Close$10.34
Average Volume (3M)39.85K
Market Cap
Enterprise ValueN/A
Total Cash (Recent Filing)$59.18M
Total Debt (Recent Filing)$33.57M
Price to Earnings (P/E)-0.5
Nov 09, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-19.91
Shares Outstanding2,542,716
10 Day Avg. Volume25,688
30 Day Avg. Volume39,855
Standard Deviation0.86
Financial Highlights & Ratios
Price to Book (P/B)1.55
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.00
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda0.00
Price Target Upside204.52% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Kala Pharmaceuticals Inc’s price range in the past 12 months?
Kala Pharmaceuticals Inc lowest stock price was $3.54 and its highest was $56.72 in the past 12 months.
    What is Kala Pharmaceuticals Inc’s market cap?
    Currently, no data Available
    When is Kala Pharmaceuticals Inc’s upcoming earnings report date?
    Kala Pharmaceuticals Inc’s upcoming earnings report date is Nov 09, 2023 which is in 47 days.
      How were Kala Pharmaceuticals Inc’s earnings last quarter?
      Kala Pharmaceuticals Inc released its earnings results on Aug 04, 2023. The company reported -$4.36 earnings per share for the quarter, missing the consensus estimate of -$3.187 by -$1.173.
        Is Kala Pharmaceuticals Inc overvalued?
        According to Wall Street analysts Kala Pharmaceuticals Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Kala Pharmaceuticals Inc pay dividends?
          Kala Pharmaceuticals Inc does not currently pay dividends.
          What is Kala Pharmaceuticals Inc’s EPS estimate?
          Kala Pharmaceuticals Inc’s EPS estimate is -$3.46.
            How many shares outstanding does Kala Pharmaceuticals Inc have?
            Kala Pharmaceuticals Inc has 2,542,716 shares outstanding.
              What happened to Kala Pharmaceuticals Inc’s price movement after its last earnings report?
              Kala Pharmaceuticals Inc reported an EPS of -$4.36 in its last earnings report, missing expectations of -$3.187. Following the earnings report the stock price went down -1.603%.
                Which hedge fund is a major shareholder of Kala Pharmaceuticals Inc?
                Among the largest hedge funds holding Kala Pharmaceuticals Inc’s share is Baker Bros Advisors LP. It holds Kala Pharmaceuticals Inc’s shares valued at 2M.


                  Kala Pharmaceuticals Stock Smart Score

                  This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Kala Pharmaceuticals Inc

                  Kala Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the development and commercialization of therapeutics using proprietary nanoparticle-based Mucus Penetrating Particles, or MPP, technology, with an initial focus on the treatment of eye diseases. The company was founded by Justin Hanes, Robert S. Langer and Colin R. Gardner in 2009 and is headquartered in Watertown, MA.


                  Top 5 ETFs holding KALA

                  Market Value
                  Smart Score
                  iShares Core S&P Total U.S. Stock Market ETF
                  Up to five ETFs with an Outperform Smart Score that hold KALA. The ETFs are listed according to market value of KALA within the ETF

                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Ocular Therapeutix
                  Bausch Health Companies

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis